Yifan Pharmaceutical Co., Ltd. (002019.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap14.57B
Enterprise Value15.94B
P/E Ratio34.71
PEG Ratio-2.02
Price/Sales Ratio2.41
Price/Book Ratio1.37
Enterprise/Revenue2.67
Enterprise/EBITDA19.41

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.07
Operating Margin0.08
AD

Management Effectiveness

Return On Assets0.03
Return On Equity0.04

Income Statement

Revenue5.13B
Revenue/Share4.16
Gross Profit2.41B
EBITDA825.51M
Net Income402.02M
Diluted EPS0.33

Balance Sheet

Total Cash751.21M
Total Cash/Share0.62
Total Debt2.08B
Total Debt/Equity0.23
Current Ratio1.34
Book Value Per Share7.2

Price History

52-Week Change-24.15
52-Week High16.66
52-Week Low9.39
Moving Average 50 Days10.84
Moving Average 200 Days12.38

Statistics

Average Volume14.79M
Shares Outstanding1.22B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.1
Trailing Annual Dividend Yield1
Payout Ratio0.48
Last Split Factor5:2
Last Split DateMay 16, 2016
AD